Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 124, 2004 - Issue 10
Submit an article Journal homepage
21
Views
5
CrossRef citations to date
0
Altmetric
Original Paper

Application of tissue microarray: Evaluation of the expression of S-100-positive dendritic cells, tumor suppressor gene p63 and tissue inhibitor of metalloproteinase-1 in laryngeal carcinoma

Pin Dong From the Department of Otolaryngology—Head & Neck Surgery, The Shanghai First People's Hospital of Shanghai Jiao Tong University, Shanghai, People's Republic of China
,
Xiaoyan Li From the Department of Otolaryngology—Head & Neck Surgery, The Shanghai First People's Hospital of Shanghai Jiao Tong University, Shanghai, People's Republic of China
,
Zhenghua Zhu From the Department of Otolaryngology—Head & Neck Surgery, The Shanghai First People's Hospital of Shanghai Jiao Tong University, Shanghai, People's Republic of China
,
Ziwei Yu From the Department of Otolaryngology—Head & Neck Surgery, The Shanghai First People's Hospital of Shanghai Jiao Tong University, Shanghai, People's Republic of China
,
Guangzhong Lu From the Department of Otolaryngology—Head & Neck Surgery, The Shanghai First People's Hospital of Shanghai Jiao Tong University, Shanghai, People's Republic of China
,
Zhenfeng Sun From the Department of Otolaryngology—Head & Neck Surgery, The Shanghai First People's Hospital of Shanghai Jiao Tong University, Shanghai, People's Republic of China
&
Sang Wang From the Department of Otolaryngology—Head & Neck Surgery, The Shanghai First People's Hospital of Shanghai Jiao Tong University, Shanghai, People's Republic of ChinaCorrespondence[email protected]
 show all
Pages 1204-1207 | Received 24 Feb 2004, Accepted 15 May 2004, Published online: 08 Jul 2009

References

  • Epstein JR, Leung AP, Lee KH, Walt DR. High-density, microsphere-based fiber optic DNA microarrays. Bio-sens Bioelectron 2003; 18: 541–6.
  • Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarray for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844–7.
  • Gregersen PK, Brehrens TW. Fine mapping the pheno-type in autoimmune disease: the promise and pitfalls of DNA microarray technologies. Genes Immun 2003; 4: 175–6.
  • Camp RL, Dolled-Filhart M, King BL, Rimm DL. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res 2003; 63: 1445–8.
  • Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer 1990; 66: 2012–6.
  • Gallo O, Libonati GA, Gallina E, Fini-Storchi 0, Giannini A, Urso C, et al. Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1991; 117: 1007–10.
  • Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997; 387: 713–7.
  • Kaelin WG. The P53 gene family. Oncogene 1999; 18: 7701–5.
  • Bates S, Vonsden KH. Mechanisms of p53-mediated apoptosis. Cell Mol Life Sci 1999; 55: 28–37.
  • Pruneri G, Pignataro L, Manzotti M, Carboni N, Ronchetti D, Neri A, et al. p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity. Lab Invest 2002; 82: 1327–34.
  • Nemunaitis J, Poole C, Primrose J, Rosemurgy A, Malfetano J, Brown P, et al. Combined analysis of studies of the effect of the matrix metalloproteinase inhibitor marimastat on serum tumour markers in advanced cancer: selection of a biologically active and tolerable dose for long term studies. Clin Cancer Res 1998; 4: 1101–9.
  • Kugler A. Matrix metalloproteinases and their inhibi-tors. Anticancer Res 1999; 19: 1589–92.
  • Danilewicz M, Sikorska B, Wagrowska-Danilewicz M. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer. Med Sci Monit 2003; 9: 42–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.